PDA

View Full Version : MedWorm


  1. Naltrexone restores clomiphene sensitivity in pcos
  2. Pcos a major risk factor for psychosocial and emotional impairment
  3. Genetics of high testosterone levels in pcos uncovered
  4. Ovarian diathermy suitable for first-line ovulation induction in selected pcos patien
  5. Obesity linked with severe ovulatory dysfunction in pcos
  6. [oocyte and embryo quality and outcome of icsi cycles in patients with polycystic ova
  7. Metformin treatment increases DHEAS levels in infertile PCOS women
  8. LAP index accurately identifies PCOS patients at risk for cardiovascular disease
  9. Metformin Therapy Restores Normal Menstrual Cycles, Reduces the Ovarian Size and Volu
  10. AMH levels unaffected by weight loss in obese women with PCOS
  11. Ser/Ser FSHR genotype linked to poor CC response in women with PCOS
  12. Lifestyle modification best treatment for PCOS
  13. PCOS Development May Begin With Insulin Resistance
  14. Letrozole plus progesterone increases clinical pregnancy rates in PCOS
  15. Simple physician advice, follow-up sufficient for obese PCOS women to lose weight
  16. Simple physician advice, follow-up sufficient for obese PCOS women to lose weight
  17. Letrozole plus progesterone increases clinical pregnancy rates in PCOS
  18. PCOS diagnosis related to parental history of vascular dysfunction
  19. Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patie
  20. BMI Tied to Depression in PCOS
  21. Vaginal contraceptive ring ‘best for hyperinsulinemic women with PCOS’
  22. OC/Metformin Combo Betters Lipids in PCOS
  23. No Link Seen Between PCOS and Small Fetal Size
  24. No association of the G972S polymorphism of the insulin receptor substrate-1 gene wit
  25. PCOS phenotype, features define risk for adverse obstetric outcomes
  26. Estrone, free testosterone levels accurate biomarkers for PCOS
  27. HMW adiponectin reduced in PCOS independent of BMI, insulin resistance
  28. Day 3 AMH levels good marker of ovarian response in PCOS patients
  29. Polycystic Ovarian Syndrome (PCOS)
  30. IVF outcomes comparable in PCOS and PCO-only women
  31. Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment
  32. Some PCOS Therapies Can Lower CVD Risk
  33. Health Tip: Understanding PCOS
  34. National survey on management of weight reduction in PCOS women in the United Kingdom
  35. All Teens With PCOS Need an OGTT, Regardless of Weight
  36. Short-term exercise and diet change may improve fertility in PCOS
  37. Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-an
  38. Statins No Extra Help in Women With PCOS
  39. The effect of low dose human chorionic gonadotropin on follicular response and oocyte
  40. Metformin and Exercise Problematic in Obese PCOS Women
  41. Dyslipidemia Common in Women With PCOS
  42. Modulating PUFA Mix Improves Androgenic Profiles in PCOS
  43. Analysis of factors predicting success of metformin and clomiphene treatment for wome
  44. PCOS Appears to Be Manifesting at Younger Ages
  45. Does laparoscopic ovarian diathermy change clomiphene-resistant PCOS into clomiphene-
  46. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic revie
  47. A randomized trial of ovulation induction with two different doses of Letrozole in wo
  48. Girls With PCOS Have CVD, Diabetes Risk Factors
  49. Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS: a pro
  50. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-i
  51. Clinical Approaches to PCOS: A Survey of the NASPAG Membership
  52. Androgen Levels Do Not Predict PCOS Phenotypes in Adolescents and Young Adults
  53. Is Metformin Indicated as Primary Ovulation Induction Agent in Women with PCOS? A Sys
  54. Aromatase inhibitors for PCOS: a systematic review and meta-analysis
  55. Is Metformin Indicated as Primary Ovulation Induction Agent in Women with PCOS A Syst
  56. IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH anta